JBSAY JBS SA (QX)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 6-K

 

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or

15d-16 of the Securities Exchange Act of 1934

 

For the month of November 2024

 

Commission File Number: 333-155412

 

 

JBS S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant’s name into English)

 

Av. Marginal Direita do Tietê

500, Bloco I, 3rd Floor

São Paulo, SP, Brazil

(Address of principal executive offices)

 

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F:  ☒      Form 40-F: ☐

 

  

 

EXHIBIT INDEX

 

Exhibit Number		Description of Document
99.1		Notice to the Market (English translation).

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 26, 2024

 

	JBS S.A.
	By:	/s/ Guilherme Perboyre Cavalcanti
	Name:	Guilherme Perboyre Cavalcanti
	Title:	Chief Financial and Investment Relations Officer

 

 

 

Exhibit 99.1

 

 

 

 

NOTICE TO THE MARKET

 

JBS S.A. (B3: JBSS3, OTCQX: JBSAY, “JBS”) hereby informs to its shareholders and the market, in accordance with article 12 of the Resolution of the Securities and Exchange Commission No. 44/21, that it received on November 25, 2024 a notice from Capital Research Global Investors (“CRGI”), informing that it has reduced their stake in common shares issued by JBS.

 

CRGI managed 110,968,019 of the JBS’ common shares, corresponding to 5.00% of the total shares issued and informed that it started to manage a total of 110,348,453 of JBS’ common shares, which represent 4.97% of the total shares issued.

CRGI further declared that:

 

(i)

this is a minority investment that does not change the composition of control or the administrative structure of JBS;

 

(ii)

there is no quantity of JBS shares targeted by CRGI; and

 

(iii)

there are no other securities and derivative financial instruments referenced in such shares held, directly or indirectly, by CRGI or a person linked to it, nor any agreement or contract regulating the exercise of voting rights or the purchase and sale of securities issued by JBS in which CRGI or a person linked to it is a party.

 

The original version of the correspondence received from CRGI is filed at the JBS’ headquarter.

 

São Paulo, November 26, 2024.

 

Guilherme Perboyre Cavalcanti

Global CFO and Investor Relations Officer

---